bell
The current prices are delayed by 15 mins, login to check live prices.
Syngene International Ltd share price logo

Syngene International Ltd

(SYNGENE)

₹923.850.73%

as on 04:01PM, 13 Sep 2024

Overview
News
Financials
Q1 2024 Results
Technicals
F&O

Analyst Rating

based on 8 analysts

HOLD

50.00%

Buy

0.00%

Hold

50.00%

Sell

Based on 8 analysts offering long term price targets for Syngene International Ltd. An average target of ₹760.62

Source: S&P Global Market Intelligence

Syngene International Ltd Share analysis

Syngene International Ltd price forecast by 8 analysts

Downside of-17.67%

High

₹925

Target

₹760.62

Low

₹640

Syngene International Ltd target price ₹760.62, a slight downside of -17.67% compared to current price of ₹923.85. According to 8 analysts rating.

Source: S&P Global Market Intelligence

Performance

  • Day's Low

    Day's High

    ₹911.2
    ₹928.5
  • 52 Week's Low

    52 Week's High

    ₹607.65
    ₹938
1 Month Return+ 13.25 %
3 Month Return+ 30.66 %
1 Year Return+ 11.02 %
Previous Close₹917.15
Open₹917.15
Volume3.43L
Upper Circuit-
Lower Circuit-
Market Cap₹36,918.68Cr

Key Statistics

P/E Ratio75.29
PEG Ratio259.63
Market Cap₹36,918.68 Cr
P/B Ratio6.73
EPS12.69
Dividend Yield0.18
SectorHealthcare
ROE11.95

Peer Comparison

Company
Analyst ViewMarket Cap5 Year CAGRDebt to Asset RatioNet ProfitYearly Revenue
HOLD₹36,918.68 Cr38.26%0.56₹510 Cr₹3,488 Cr
BUY₹16,634.57 Cr4.32%0.52₹602 Cr₹2,851 Cr
BUY₹91,491.38 Cr29.24%0.56₹3,168 Cr₹29,001 Cr
HOLD₹1,12,708.27 Cr72.33%0.64₹3,854 Cr₹19,547 Cr
BUY₹63,092.63 Cr40.15%0.53NANA

Company Information

Syngene International Limited is a India-based research, development, and manufacturing services organization driven by a team of 5200 scientists. It focuses primarily on the pharmaceutical and biotechnology sectors, and also provides services for nutrition, animal health, consumer goods, and other chemical sectors. The company’s health-related services extends across all major therapy areas and modalities. The operations are spread across 2 million sq. ft. with facilities at Bangalore, Hyderabad, and Mangalore. Syngene International Limited was incorporated in 1993 and consistently has entered into partnerships for research and development. This helped Syngene International cross an annual turnover of Rs 1000 crore in the year 2016. Over the years leading up to 2021, Syngene International expanded its research collaboration with companies such as Abbott, Bristol Myers Squibb, Herbalife, and Glaxo Smith Kline. It also commissioned new facilities and added bioreactors and microbial manufacturing capacity to strengthen biologics manufacturing. With investments in R&D and strengthening scientific capabilities, Syngene International continues to provide integrated drug discovery services.

Share Price: ₹923.85 per share as on 13 Sep, 2024 04:01 PM
Market Capitalisation: ₹36,918.68Cr as of today
Revenue: ₹789.70Cr as on June 2024 (Q2 24)
Net Profit: ₹75.70Cr as on June 2024 (Q2 24)
Listing date: 11 Aug, 2015
Chairperson Name: Kiran Mazumdar Shaw
OrganisationSyngene International Ltd
Headquarters
IndustryHealthcare
E-voting on sharesClick here to vote

Key events for Syngene International Ltd

  • Syngene Positioned for Growth Amid Biosecure Act - 12 Sep, 2024

    Shaw highlights the Biosecure Act's potential to shift business from Chinese firms to Indian pharma, benefiting Syngene with a 50% increase in RFPs and strong long-term contracts.

  • Syngene Expands Supply Chain Amid Demand Surge - 10 Sep, 2024

    Syngene International is expanding its supply chain options to reduce reliance on China, reporting a 50% increase in RFPs. Despite a 19% dip in PAT, the stock rose 3.97%. Analysts note strong traction from long-term contracts with multinationals.

Insights on Syngene International Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, SYNGENE stock has moved up by 3.3%

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 12.59% to 13.63% in Jun 2024 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Shree Ganesh Remedies Ltd has given 134.4% return, outperforming this stock by 95.9%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Shree Ganesh Remedies Ltd has given 72.7% return, outperforming this stock by 61.6%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 188.6 Cr → 75.7 Cr (in ₹), with an average decrease of 59.9% per quarter

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 20.92% to 20.63% in Jun 2024 quarter

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 8.17% to 7.42% in Jun 2024 quarter

  • imgNEGATIVE IMPACT

    Promoter Holding Down

    img

    Promoters have decreased holdings from 54.79% to 54.72% in Jun 2024 quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 933.0 Cr → 839.8 Cr (in ₹), with an average decrease of 10.0% per quarter

Company Financials

Value in ₹ crore
DetailsQ'2 23Q'3 23Q'4 23Q'1 24Q'2 24
Revenue₹808.10Cr (-)₹910.10Cr (↑12.62%)₹853.50Cr (↓6.22%)₹916.90Cr (↑7.43%)₹789.70Cr (↓13.87%)
Net Income₹93.40Cr (-)₹116.50Cr (↑24.73%)₹111.50Cr (↓4.29%)₹188.60Cr (↑69.15%)₹75.70Cr (↓59.86%)
Net Profit Margin11.56% (-)12.80% (↑10.73%)13.06% (↑2.03%)20.57% (↑57.50%)9.59% (↓53.38%)
Value in ₹ crore
Details2021202220232024
Total Assets₹4,977.30Cr (-)₹5,686.00Cr (↑14.24%)₹5,970.10Cr (↑5.00%)₹5,962.40Cr (↓0.13%)
Total Liabilities₹2,159.00Cr (-)₹2,394.00Cr (↑10.88%)₹2,351.20Cr (↓1.79%)₹1,770.90Cr (↓24.68%)
Value in ₹ crore
Details20202021202220232024
Operating Cash Flow₹677.40Cr (-)₹698.00Cr (↑3.04%)₹582.20Cr (↓16.59%)₹838.40Cr (↑44.01%)₹913.40Cr (↑8.95%)

Index Inclusions

BSE Healthcare

₹44,309.16

0.05 (22.52%)

Nifty Midcap 100

₹60,034.05

0.66 (393.75%)

BSE 500

₹37,757.29

0.1 (36.4%)

S&P BSE 250 LargeMidCap

₹11,157.15

0.02 (2.18%)

BSE 200

₹11,752.02

0 (0.01%)

BSE Small-Cap

₹57,128.04

0.95 (538.11%)

Nifty 200

₹14,391.40

-0.02 (-3.25%)

Nifty Healthcare

₹14,695.45

-0.17 (-25.5%)

S&P BSE 400 MidSmallCap

₹12,925.21

0.63 (80.95%)

Nifty LargeMidcap 250

₹16,714.85

0.24 (40.75%)

S&P BSE SmallCap Select

₹8,490.71

0.94 (79.02%)

S&P BSE AllCap

₹11,052.65

0.16 (17.17%)

S&P BSE 150 MidCap

₹16,976.34

0.54 (91.38%)

Nifty MidSmallcap 400

₹20,931.20

0.73 (151.65%)

Nifty 500

₹23,928.20

0.09 (20.85%)

Nifty Midcap 150

₹22,190.35

0.65 (142.65%)

Shareholding Pattern

InvestorsHoldings %FY Quarter3M change
Promoter Holdings
54.72%
-0.13
Foreign Institutions
20.63%
-1.40
Mutual Funds
13.63%
8.29
Retail Investors
7.42%
-9.21
Others
3.59%
2.05

Key Indicators

Details20202021202220232024
Book Value Per Share (₹)54.470.5482.2890.13105.92
Details20202021202220232024
Earning Per Share (₹)10.310.129.8811.5712.69
Details20202021202220232024
Return On Equity %17.2816.1712.8913.6911.95
Details20202021202220232024
Return On Assets %9.78.136.967.788.55

Syngene International Ltd Valuation

Syngene International Ltd in the last 5 years

  • Overview

  • Trends

Lowest (23.09x)

March 31, 2020

Today (75.29x)

September 13, 2024

Industry (96.83x)

September 13, 2024

Highest (75.44x)

September 10, 2024

LowHigh

Earnings and Dividends

  • Syngene International Ltd Earnings Results

    Syngene International Ltd’s net profit fell -18.95% since last year same period to ₹75.70Cr in the Q1 2024-2025. On a quarterly growth basis, Syngene International Ltd has generated -59.86% fall in its net profits since last 3-months.

    Read More about Earnings Results
  • Syngene International Ltd Dividends April,2024

    In the quarter ending March 2024, Syngene International Ltd has declared dividend of ₹1.25 - translating a dividend yield of 0.27%.

    Read More about Dividends

Technicals Summary

Bearish

Neutral

Bullish

Bullish

Syngene International Ltd is currently in a Bullish trading position according to technical analysis indicators.

Frequently Asked Questions

  • Get a PAN card.
  • Open a Demat account.
  • Open a Trading account.
  • Link your Demat account to your Trading account.
  • Fund your Trading account.
  • Place an order to buy Syngene International Ltd shares.

Syngene International Ltd (SYNGENE) share price today is ₹923.85

Syngene International Ltd is listed on NSE

Syngene International Ltd is listed on BSE

  • Today’s highest price of Syngene International Ltd is ₹928.5.
  • Today’s lowest price of Syngene International Ltd is ₹911.2.

PE Ratio of Syngene International Ltd is 75.29

PE ratio = Syngene International Ltd Market price per share / Syngene International Ltd Earnings per share

Today’s traded volume of Syngene International Ltd(SYNGENE) is 3.43L.

Today’s market capitalisation of Syngene International Ltd(SYNGENE) is ₹36918.68Cr.

Syngene International Ltd(SYNGENEPrice
52 Week High
₹938
52 Week Low
₹607.65

Syngene International Ltd(SYNGENE) share price is ₹923.85. It is down -1.51% from its 52 Week High price of ₹938

Syngene International Ltd(SYNGENE) share price is ₹923.85. It is up 52.04% from its 52 Week Low price of ₹607.65

Syngene International Ltd(SYNGENEReturns
1 Day Returns
6.7%
1 Month Returns
13.25%
3 Month Returns
30.66%
1 Year Returns
11.02%